Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers

Neuroscience

Volumn 157, Issue 1, 2008, Pages 105-119

  Garcia Fuster M J ^a   Ramos Miguel, A ^a   Rivero, G ^a,b   La Harpe, R ^c   Meana, J J ^b   Garcia Sevilla J A ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

Author keywords

Fas receptor apoptotic pathway; mitochondrial apoptotic pathway; opiate addiction; postmortem human brain; pro and anti apoptotic proteins

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 8; CYTOCHROME C; DIAMORPHINE; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; METHADONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OPIATE; PROTEIN BAX; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG ABUSE; FEMALE; HUMAN; MALE; NERVE CELL PLASTICITY; OPIATE ADDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ACUTE DISEASE; ADULT; AGING; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CHRONIC DISEASE; FEMALE; HAIR; HUMANS; MALE; MIDDLE AGED; NARCOTICS; NEURONAL PLASTICITY; OPIOID-RELATED DISORDERS; PREFRONTAL CORTEX; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; SYNAPSES; YOUNG ADULT;

EID: 54549124411     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.09.002     Document Type: Article

References (73)

1. Ammon S., Mayer P., Riechert U., Tischmeyer H., and Höllt V. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Mol Brain Res 112 (2003) 113-125
2. Ballesteros-Yáñez I., Ambrosio E., Benavides-Piccione R., Pérez J., Torres I., Miguéns M., García-Lecumberri C., and De Felipe J. The effects of morphine self-administration on cortical pyramidal cell structure in addiction-prone Lewis rats. Cereb Cortex 17 (2007) 238-249
3. Bi F.F., Xiao B., Hu Y.Q., Tian F.F., Wu Z.G., Ding L., and Zhou X.F. Expression and localization of Fas-associated proteins following focal cerebral ischemia in rats. Brain Res 1191 (2008) 30-38
4. Boronat M.A., García-Fuster M.J., and García-Sevilla J.A. Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain. Br J Pharmacol 134 (2001) 1263-1270
5. Boumba V.A., Ziavrou K.S., and Vougiouklakis T. Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. Int J Toxicol 25 (2006) 143-163
6. Burke R.E. Programmed cell death and new discoveries in the genetics of parkinsonism. J Neurochem 104 (2008) 875-890
7. Cunha-Oliveira T., Rego A.C., Garrido J., Borges F., Macedo T., and Oliveira C.R. Street heroin induces mitochondrial dysfunction and apoptosis in rat cortical neurons. J Neurochem 101 (2007) 543-554
8. Dargusch R., Piasecki D., Tan S., Liu Y., and Schubert D. The role of Bax in glutamate-induced nerve cell death. J Neurochem 76 (2001) 295-301
9. Desbarats J., Birge R.B., Minouni-Rongy M., Weistein D.E., Palerme J.S., and Newell M.K. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol 5 (2003) 118-125
10. Engidawork E., Gulesserian T., Yoo B.C., Cairns N., and Lubec G. Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. Biochem Biophys Res Comm 281 (2001) 84-93
11. Everitt B.J., Hutcheson D.M., Ersche K.D., Pelloux Y., Dalley J.W., and Robbins T.W. The orbital prefrontal cortex and drug addiction in laboratory animals and humans. Ann N Y Acad Sci 1121 (2007) 576-597
12. Ferrer-Alcón M., La Harpe R., Guimón J., and García-Sevilla J.A. Downregulation of neuronal cdk5/p35 in opioid addicts and opiate-treated rats: Relation to neurofilament phosphorylation. Neuropsychopharmacology 28 (2003) 947-955
13. Ferrer-Alcón M., García-Fuster M.J., La Harpe R., and García-Sevilla J.A. Long-term regulation of signalling components of adenylyl cyclase and mitogen-activated protein kinasein the pre-frontal cortex of human opiate addicts. J Neurochem 90 (2004) 220-230
14. Fugelstad A., Ahlner J., Brandt L., Ceder G., Eksborg S., Rajs J., and Beck O. Use of morphine and 6-monoacetylmorphine in blood for the evaluation of possible risk factors for sudden death in 192 heroin users. Addiction 98 (2003) 463-470
15. Fuster J.M. The prefrontal cortex-An update: Time is of the essence. Neuron 30 (2001) 319-333
16. García-Fuster M.J., Ferrer-Alcón M., Miralles A., and García-Sevilla J.A. Modulation of Fas receptor proteins and dynamin during opiate addiction and induction of opiate withdrawal in rat brain. Naunyn Schmiedebergs Arch Pharmacol 368 (2003) 421-431
17. García-Fuster M.J., Ferrer-Alcón M., Miralles A., and García-Sevilla J.A. Deglycosylation of Fas receptor and chronic morphine treatment up-regulate high molecular mass Fas aggregates in the rat brain. Eur J Pharmacol 496 (2004) 63-69
18. García-Fuster M.J., Miralles A., and García-Sevilla J.A. Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: Regulation by the ERK1/2 MAP kinase pathway. Neuropsychopharmacology 32 (2007) 399-411
19. García-Fuster M.J., Clinton S.M., Watson S.J., and Akil H. Effect of cocaine on Fas-associated protein with death domain (FADD) in the rat brain: Individual differences in a model of differential vulnerability to drug abuse. Neuropsychopharmacology (2008) in press. doi:10.1038/npp.2008.88
20. García-Fuster M.J., Ramos-Miguel A., Miralles A., and García-Sevilla J.A. Opioid receptor agonists enhance the phosphorylation state of Fas-associated death domain (FADD) protein in the rat brain: Functional interactions with casein kinase Iα, Gαi proteins, and ERK1/2 signaling. Neuropharmacology, Neuropharmacol 55 (2008) 886-899
21. García-Sevilla J.A., García-Fuster M.J., Davidson A., Rivero G., La Harpe R., and Meana J.J. Regulation of the apoptotic machinery in the prefrontal cortex of human opioid abusers. Eur Neuropsychopharmacol 17 Suppl 4 (2007) S553-S554
22. Garnett T.O., Filippova M., and Duerksen-Hughes P.J. Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis. Cell Death Differ 13 (2006) 1915-1926
23. Gilman C.P., and Mattson M.P. Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility?. Neuromol Med 2 (2002) 197-213
24. Goldberger B.A., Cone E.J., Grant T., Caplan Y.H., Levine B.S., and Smialek J.E. Disposition of heroin and its metabolites in heroin-related deaths. J Anal Toxicol 18 (1994) 22-28
25. Grange-Midroit M., García-Sevilla J.A., Ferrer-Alcón M., La Harpe R., Walzer C., and Guimón J. G protein-coupled receptor kinases, β-arrestin-2 and associated regulatory proteins in the human brain: postmortem changes, effect of age and subcellular distribution. Mol Brain Res 101 (2002) 39-51
26. Gruber S.A., Silveri M.M., and Yurgelun-Todd D.A. Neuropsychological consequences of opiate use. Neuropsychol Rev 17 (2007) 299-315
27. Hardy J.A., Wester P., Winblad B., Gezelius C., Bring G., and Eriksson A. The patients dying after long terminal phase have acidotic brains: Implications for biochemical measurements on autopsy tissue. J Neural Transm 61 (1985) 253-264
28. Jonas E. BCL-xl regulates synaptic plasticity. Mol Interv 6 (2006) 208-222
29. Kalivas P.W., and O'Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 33 (2008) 166-180
30. Kataoka T. The caspase-8 modulator c-FLIP. Crit Rev Immunol 25 (2005) 31-58
31. Korsmeyer S.J., Shutter J.R., Veis D.J., Merry D.E., and Oltvai Z.N. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4 (1993) 327-332
32. Krantic S., Mechawar N., Reix S., and Quirino R. Apoptosis-inducing factor: A matter of neuron life and death. Prog Neurobiol 81 (2007) 179-196
33. Krueger A., Schmitz I., Baumann S., Krammer P.H., and Kirchhoff S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 276 (2001) 20633-20640
34. Kumar S. Caspase function in programmed cell death. Cell Death Differ 14 (2007) 32-43
35. Li J.Z., Vawter M.P., Walsh D.M., Tomita H., Evans S.J., Choudary P.V., Lopez J.F., Avelar A., Shokoohi V., Chung T., Mesarwi O., Jones E.G., Watson S.J., Akil H., Bunney Jr. W.E., and Myers R.M. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 13 (2004) 609-616
36. Liao D., Lin H., Law P.Y., and Loh H.H. Mu-opioid receptors modulate the stability of dendritic spines. Proc Natl Acad Sci U S A 102 (2005) 1725-1730
37. Liao D., Grigoriants O.O., Wang W., Wiens K., Loh H.H., and Law P.Y. Distinct effects of individual opioids on the morphology of spines depend upon the internalization of mu opioid receptors. Mol Cell Neurosci 35 (2007) 456-469
38. Lyoo I.K., Pollack M.H., Silveri M.M., Ahn K.H., Diaz C.I., Hwang J., Kim S.J., Yurgelun-Todd D.A., Kaufman M.J., and Renshaw P.F. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology 184 (2006) 139-144
39. Mao J., Sung B., Ji R.R., and Lim G. Neuronal apoptosis associated with morphine tolerance: Evidence for an opioid-induced neurotoxic mechanism. J Neurosci 22 (2002) 7650-7661
40. Marie-Claire C., Courtin C., Roques B.P., and Noble F. Cytoskeletal genes regulation by chronic morphine treatment in rat striatum. Neuropsychopharmacology 29 (2004) 2208-2215
41. Mattson M.P., and Gleichmann M. The neuronal death protein Par-4 mediates dopaminergic synaptic plasticity. Mol Interv 5 (2005) 278-281
42. Merrill J., Garvey T., and Rosson C. Methadone concentrations taken as indicating deaths due to overdose need to be reviewed. BMJ 313 (1996) 1481
43. Miller E.K., and Cohen J.D. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 24 (2001) 167-202
44. Morón J.A., Abul-Husn N.S., Rozenfeld R., Dolios G., Wang R., and Devi L.A. Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins. Mol Cell Proteom 6 (2007) 29-42
45. Motulsky H. Intuitive biostatistics (1995), Oxford University Press, New York
46. Nutt D., King L.A., Saulsbury W., and Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 369 (2007) 1047-1053
47. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
48. Pérez-San Emeterio E., Tramullas M., and Hurlé M.A. Modulation of apoptosis in the mouse brain after morphine treatments and morphine withdrawal. J Neurosci Res 83 (2006) 1352-1361
49. Perret G., Déglon J.J., Kreek M.J., Ho A., and La Harpe R. Lethal methadone intoxications in Geneva, Switzerland, from 1994 to 1998. Addiction 95 (2000) 1647-1653
50. Peter M.E., and Krammer P.H. The CD95 (APO-1/Fas) DISC and beyond. Cell Death Differ 10 (2003) 26-35
51. Pezawas L.M., Fischer G., Diamant K., Schneider C., Schindler S.D., Thurnher M., Ploechl W., Eder H., and Kasper S. Cerebral CT findings in male opioid-dependent patients: stereological, planimetric and linear measurements. Psychiatry Res 83 (1998) 139-147
52. Preece P., and Cairns N.J. Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Mol Brain Res 118 (2003) 60-71
53. Pujol M.L., Cirimele V., Tritsch P.J., Villain M., and Kintz P. Evaluation of the IDS One-Step™ ELISA kits for the detection of illicit drugs in hair. Forensic Sci Int 170 (2007) 189-192
54. Putt K.S., Beilman G.J., and Hergenrother P.J. Direct quantitation of poly(ADP-ribose) polymerase (PARP) activity as a means to distinguish necrotic and apoptotic death in cell and tissues samples. Chembiochem 6 (2005) 53-55
55. Ramos-Miguel A., Miralles A., and García-Sevilla J.A. Morphine-induced locomotor sensitization increases FADD phosphorylation in rat brain. Eur Neuropsychopharmacol 17 Suppl 4 (2007) S251-S252
56. Reed J.C. Cytochrome c: Can't live with it-Can't live without it. Cell 91 (1997) 559-562
57. Repetto M.R., and Repetto M. Habitual, toxic, and lethal concentrations of 103 drugs of abuse in humans. Clin Toxicol 35 (1997) 1-9
58. Sastry P.S., and Rao K.S. Apoptosis and the nervous system. J Neurochem 74 (2000) 1-20
59. Schoenbaum G., and Shaham Y. The role of orbitofrontal cortex in drug addiction: A review of preclinical studies. Biol Psychiatry 63 (2008) 256-262
60. Stan A.D., Ghose S., Gao X.M., Roberts R.C., Lewis-Amezcua K., Hatanpaa K.J., and Tamminga C.A. Human postmortem tissue: What quality markers matter?. Brain Res 1123 (2006) 1-11
61. L protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death. J Neurosci 27 (2007) 6633-6646
62. Tegeder I., and Geisslinger G. Opioids as modulators of cell death and survival-unraveling mechanisms and revealing new indications. Pharmacol Rev 56 (2004) 351-369
63. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R., Poirier G.G., Salvesen G.S., and Dixit V.M. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81 (1995) 801-809
64. Tramullas M., Martínez-Cué C., and Hurlé M.A. Chronic methadone treatment and repeated withdrawal impair cognition and increase the expression of apoptosis-related proteins in mouse brain. Psychopharmacology 193 (2007) 107-120
65. Tramullas M., Martínez-Cué C., and Hurlé M.A. Chronic administration of heroin to mice produces up-regulation of brain apoptosis-related proteins and impairs spatial learning and memory. Neuropharmacology 54 (2008) 640-652
66. Tschopp J., Irmler M., and Thome M. Inhibition of Fas death signals by FLIPs. Curr Opin Immunol 10 (1998) 552-558
67. Volkow N.D., Fowler J.S., and Wang G.J. The addicted human brain: insights from imaging studies. J Clin Invest 111 (2003) 1444-1451
68. Walensky L.D. BCL-2 in the crosshairs: tipping the balance of life and death. Cell Death Differ 13 (2006) 1339-1350
69. Walhovd K.B., Moe V., Slinning K., Due-Tønnessen P., Bjørnerud A., Dale A.M., van der Kouwe A., Quinn B.T., Kosofsky B., Greve D., and Fischl B. Volumetric cerebral characteristics of children exposed to opiates and other substances in utero. Neuroimage 36 (2007) 1331-1344
70. Whiteside G.T., Adedoyin A., and Leventhal L. Predictive validity of animal pain models?. A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacology 54 (2008) 767-775
71. Williams J.T., Christie M.J., and Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81 (2001) 299-343
72. Yücel M., Lubman D.I., Harrison B.J., Fornito A., Allen N.B., Wellard R.M., Roffel K., Clarke K., Wood S.J., Forman S.D., and Pantelis C. A combined spectroscopic and functional MRI investigation of the dorsal anterior cingulate region in opiate addiction. Mol Psychiatry 12 (2007) 691-702
73. Zuliani C., Kleber S., Klussmann S., Wenger T., Kenzelmann M., Schreglmann N., Martínez A., del Río J.A., Soriano E., Vodrazka P., Kuner R., Groene H.J., Herr I., Krammer P.H., and Marín-Villalba A. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death Differ 13 (2006) 31-40